According to the Complaint, Evoqua purports to be a leading provider of mission critical water treatment solutions,
offering services, systems and technologies to support our customers' full water lifecycle needs. With over 200,000 installations worldwide, the Company holds leading positions in the industrial, commercial and municipal water treatment markets in North America. Evoqua offers a portfolio of differentiated, proprietary technology solutions sold under a number of brands. Evoqua claims that the customer intimacy created through its service network is a significant competitive advantage.

According to the Complaint, Ryanair is an airline operator based in Dublin, Ireland.

According to the Complaint, Align is a medical device company that purports to design, manufacture, and market products for the treatment of malocclusion or the misalignment of teeth. Invisalign is the proprietary name for the Company's clear aligners.

On November 2, 2018, Plaintiff's law firm issued a press release announcing the lawsuit. According to the press release, Synchrony is a consumer financial services company. The Complaint alleges that during the Class Period, Synchrony falsely represented that its consistent and disciplined underwriting practices had led to a higher quality loan portfolio than those of its competitors. In truth, Synchrony relaxed its underwriting standards and increasingly offered private-label credit cards to riskier borrowers to sustain growth. The truth about Synchrony's credit standards began to be revealed on April 28, 2017, when the Company announced disappointing first quarter 2017 earnings driven by poor loan performance. This news caused Synchrony's shares to decline by $5.25 per share, or nearly 16%.

According to the Complaint, India Globalization Capital, Inc. ("IGC" or the Company) operates two distinct business segments. One segment develops and commercializes cannabinoid based alternative therapies for indications such as Alzheimer's
disease, Parkinson's disease, and pain. The Company's second segment, operated since its inception, is a legacy business that involves trading commodities and heavy equipment rental.

According to the Complaint, China Zenix designs, manufactures, and sells commercial vehicle wheels to aftermarket and original equipment manufacturers in the People's Republic of China and internationally. It offers: tubed steel wheels; tubeless steel wheels; off-road steel wheels; aluminum wheels; and wheel components, such as wheel discs.

According to the Complaint, Honeywell is a multinational conglomerate that makes a variety of commercial and consumer products, engineering services, and aerospace systems. Honeywell previously owned Bendix Friction Materials ("Bendix"), a manufacturer of automotive, truck and industrial brakes. Despite known health hazards, Bendix used asbestos in its brake- and clutch-pad products until 2001. Honeywell sold Bendix in 2014.

According to the Complaint, Bank OZK is a retail and commercial bank with several subsidiaries focused on investment securities, development of real estate, and ownership of private aircraft. It was known as Bank of the Ozarks until July 16, 2018.

According to the Complaint, Dycom provides specialty contracting services through subsidiaries throughout the
United States and in Canada. Dycom's services include program management, engineering, construction, maintenance, and installation services for telecommunications providers, underground facility locating services for various utilities, including telecommunications providers, and other construction and maintenance services for electric and gas utilities.

Plaintiff's law firm issued a press release on October 25, 2018, announcing the filing of the lawsuit. According to the press release, McKesson delivers pharmaceutical and medical products and business services to retail pharmacies and institutional healthcare providers such as hospitals and health systems throughout North America and internationally. The majority of its income is derived from its business as a pharmaceutical wholesaler in which it purchases drugs in bulk directly from manufacturers and then sells and distributes those drugs to pharmacy networks, hospitals, and independent pharmacies.

Plaintiff's law firm issued a press release on October 25, 2018, announcing the filing of the lawsuit. According to the press release, Jianpu operates an on-line platform under the brand name "Rong360" in the People's Republic of China. The Company's revenues are primarily generated from fees paid by financial service providers for loan recommendation services.

Plaintiff's law firm issued a press release on October 19, 2018, announcing the filing of the lawsuit. According to the press release, the Complaint charges Camping World Holdings, Inc. ("Camping World" or the Company), certain of its officers and directors and controlling shareholders with violations of the Securities Exchange Act of 1934. Historically, the Company specialized in selling recreational vehicles ("RVs") and related services. In October 2016, Camping World went public in a $261 million initial public offering. In the months that followed, Camping World engaged in a number of strategic acquisitions. Most significantly, in May 2017, Camping World announced that it would be expanding its operations to include retail stores for outdoor sporting supplies and accessories by acquiring certain assets of Gander Mountain Co. ("Gander") from bankruptcy.

Plaintiff's law firm issued a press release on October 11, 2018, announcing the lawsuit. According to the press release, Alphabet was incorporated in 2015 and is the parent company of its leading subsidiary Google Inc. ("Google"), among others. Alphabet, through its subsidiary Google, operates a social networking website called "Google+" that allows people to communicate with their family, friends, and coworkers. Google+ users ostensibly have the ability to share and restrict the sharing of personal information according to their preferences by changing privacy settings.

According to the Complaint, Trevena, Inc. ("Trevena" or the Company) is a clinical stage biopharmaceutical company that discovers, develops and intends to commercialize therapeutics that use a novel approach to target G protein coupled receptors, or GPCRs. Using its proprietary product platform, Trevena has identified four biased ligand product candidates, including oliceridine (TRV130) to treat moderate to severe acute pain intravenously.

The Complaint alleges that throughout and before the Class Period, defendants made materially false and misleading statements and omissions regarding Acadia's business and operations. Specifically, defendants falsely stated that the quality of Acadia's U.K. operations gave it a "competitive strength" that would drive future growth and profitability. In addition, defendants caused Acadia to issue false and misleading guidance regarding the Company's actual and projected fiscal 2017 revenue, earnings before interest, taxes, depreciation and amortization ("EBITDA") and earnings per share ("EPS").

According to the Complaint, Cocrystal Pharma, Inc. ("Cocrystal" or the "Company", f/k/a/ BioZone Pharmaceuticals, Inc.) is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of hepatitis viruses, influenza viruses, and noroviruses.

According to the Complaint, Microchip Technology Incorporated ("Microchip" or the "Company") is a provider of microcontroller, mixed-signal analog and Flash-IP solutions.

Plaintiff's law firm issued a press release on September 14, 2018, announcing the filing of the lawsuit. According to the press release, the Complaint alleges that the Defendants made materially false and/or misleading statements and failed to disclose that: (1) OPKO and its Chairman and CEO, were engaged in a pump-and-dump scheme with several other individuals and companies in their investments in several penny stocks; (2) the illicit scheme allowed the Company to report revenues from this illegal conduct and would result in governmental scrutiny including a complaint filed by the U.S. Securities and Exchange Commission; and (3) consequently, Defendants' statements about OPKO's business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

According to the Complaint, USA Technologies provides wireless networking, cashless transactions, asset monitoring, and other value-added services in the United States and internationally.

Plaintiff's law firm issued a press release on August 27, 2018. According to the press release, CBS is a mass media company with operations in the entertainment, cable networks, publishing, and local media segments.